• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, October 31, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Google’s and Apple’s tightrope walk between enforcement and oversight as distributors and developers for health apps

Bioengineer by Bioengineer
January 31, 2023
in Health
Reading Time: 3 mins read
0
Stephen Gilbert
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Google and Apple dominate as a “duopoly” with their app stores. They distribute and import many thousands of health and wellness apps into the EU, some of which are approved as medical devices. New ones are added daily. Under EU rules, those who distribute health apps are also responsible for ensuring that they meet certain regulatory requirements. “There are great products and responsible developers, but there are also irresponsible actors providing tools that are neither safe nor comply with basic regulatory requirements. Google and Apple provide every medical app to every user, be they a patient or a healthcare provider. With great power comes great responsibility. Thus far, the two tech giants are fulfilling their compliance oversight duties in a patchwork fashion, in the case of Apple, or minimally, in the case of Google. They need to do better, but their ability to fulfil their legal duties is compromised by stark conflicts of interest,” said Prof. Stephen Gilbert, Professor of Medical Device Regulatory Science at the Else Kröner Fresenius Center for Digital Health at Technische Universität Dresden.

Stephen Gilbert

Credit: EKFZ

Google and Apple dominate as a “duopoly” with their app stores. They distribute and import many thousands of health and wellness apps into the EU, some of which are approved as medical devices. New ones are added daily. Under EU rules, those who distribute health apps are also responsible for ensuring that they meet certain regulatory requirements. “There are great products and responsible developers, but there are also irresponsible actors providing tools that are neither safe nor comply with basic regulatory requirements. Google and Apple provide every medical app to every user, be they a patient or a healthcare provider. With great power comes great responsibility. Thus far, the two tech giants are fulfilling their compliance oversight duties in a patchwork fashion, in the case of Apple, or minimally, in the case of Google. They need to do better, but their ability to fulfil their legal duties is compromised by stark conflicts of interest,” said Prof. Stephen Gilbert, Professor of Medical Device Regulatory Science at the Else Kröner Fresenius Center for Digital Health at Technische Universität Dresden.

The EU, in the 2017 Medical Devices Regulation introduced requirements not only for app developers, but also for app store operators, who have a legal role of distributors. Since then, these have had to ensure that apps comply with medical device regulations in the EU and inform the authorities about serious incidents related to their use. “Under the 2022 EU Digital Markets Act they will have to walk a tightrope between enforcement and oversight and making sure they do not act unfairly to the apps for which they are the duopoly platform providers. This calls into question the sustainability of a model in which a crucial aspect of healthcare infrastructure, namely app stores, is provided in such a duopolistic and conflicted manner. The EU has powers to legally enforce changes to this model. Finally, with the proposed European health data space regulation, wellness apps will be voluntarily registered and labelled in a fashion more like medical devices than consumer software. The authors explore the implications of these new regulations and propose alternative models that could resolve the apparent conflicts. “To enable the health and wellness app sector to further develop safely, these ‘wild west’ aspects of the market must be resolved. All stakeholders would benefit from improve app store models to sustainably evolve safer, better, and fairer provision of digital health applications in the EU. As EU legislation comes into force it could serve as a template for other regions globally,” concludes Gilbert.

Publication: O. Sadare, T. Melvin, H. Harvey, E. Vollebregt, S. Gilbert: Can Apple and Google continue as health app gatekeepers as well as distributors and developers? NPJ Digital Medicine. 2023 Jan 31: DOI 10.1038/s41746-023-00754-6



Journal

npj Digital Medicine

DOI

10.1038/s41746-023-00754-6

Article Title

Can Apple and Google continue as health app gatekeepers as well as distributors and developers?

Share12Tweet8Share2ShareShareShare2

Related Posts

Global Research Uncovers the Role of Bacteria in Shaping Lake and Reservoir Health

October 31, 2025

Comparing Health Worker and Non-Worker Education on Contraception

October 31, 2025

Creating Human Kidney Organoids for Porcine Transplants

October 31, 2025

Proteome Atlas Unveils Diabetic Retinopathy Risks

October 31, 2025

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1294 shares
    Share 517 Tweet 323
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    312 shares
    Share 125 Tweet 78
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    202 shares
    Share 81 Tweet 51
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    136 shares
    Share 54 Tweet 34

About

BIOENGINEER.ORG

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Global Research Uncovers the Role of Bacteria in Shaping Lake and Reservoir Health

Comparing Health Worker and Non-Worker Education on Contraception

Creating Human Kidney Organoids for Porcine Transplants

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 67 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.